|
Volumn 22, Issue 6, 1999, Pages 1001-1002
|
Implanted insulin pump may represent a chance for young women with unstable type 1. Diabetes to give birth [5]
a b c b d b a
b
HÔPITAL CIVIL
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATENOLOL;
DIHYDRALAZINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HEMOGLOBIN A1C;
INSULIN;
POLOXAMER;
ADULT;
CHILDBIRTH;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEVICE;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
DRUG IMPLANT;
FEMALE;
HUMAN;
HYPERTENSION;
INFLAMMATION;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN PUMP;
INTRAPERITONEAL DRUG ADMINISTRATION;
LASER SURGERY;
LETTER;
SEROMA;
SUBCUTANEOUS DRUG ADMINISTRATION;
ADULT;
CESAREAN SECTION;
DIABETES MELLITUS, TYPE 1;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
INFANT, NEWBORN;
INFUSION PUMPS, IMPLANTABLE;
INSULIN INFUSION SYSTEMS;
LABOR, OBSTETRIC;
MALE;
PREGNANCY;
PREGNANCY IN DIABETICS;
PREGNANCY OUTCOME;
|
EID: 0033012389
PISSN: 01495992
EISSN: None
Source Type: Journal
DOI: 10.2337/diacare.22.6.1001 Document Type: Letter |
Times cited : (2)
|
References (7)
|